10 results on '"Chen, Lingxiao"'
Search Results
2. 242 - Association of serum calcium, vitamin D, and C-reactive protein with all-cause and cause-specific mortality in an osteoarthritis population.
- Author
-
Fu, Kai, Cai, Qianying, Jin, Xinzhong, Chen, Lingxiao, Duong, Vicky, Oo, Win Min, Li, Guangyi, Zhu, Zhaohua, Ding, Changhai, Gao, Youshui, Zhang, Changqing, and Hunter, David
- Published
- 2024
- Full Text
- View/download PDF
3. A candidate multi-epitope vaccine against porcine reproductive and respiratory syndrome virus and Mycoplasma hyopneumoniae induces robust humoral and cellular response in mice.
- Author
-
Gao, Zhisong, Chen, Lingxiao, Song, Tao, Pan, Xuan, Li, Xiaojing, Lu, Guangzong, Tang, Yajie, Wu, Xiang, Zhao, Baohua, and Zhang, Ran
- Subjects
- *
MYCOPLASMA hyopneumoniae , *PORCINE reproductive & respiratory syndrome , *MERS coronavirus , *MYCOPLASMA , *RECOMBINANT proteins , *COMBINED vaccines , *PEPTIDES , *T cells - Abstract
• Recombinant epitope protein rEP-PM contains some B cell epitopes and T cell epitopes of PRRSV-GP5, PRRSV-M, Mhp-P46 and Mhp-P65 protein. • rEP-PM could induce the production of high levels of antibodies. • rEP-PM could induce the Th1-dominant cellular immune response in mice. • rEP-PM has good immunoreactivity with anti-rEP-PM, anti-PRRSV and anti-Mhp antibodies. • Anti-rEP-PM antibody could specifically recognize proteins from PRRSV and Mhp. Porcine reproductive and respiratory syndrome virus (PRRSV) and Mycoplasma hyopneumoniae (M. hyopneumoniae , Mhp) are two of the most common pathogens involved in the porcine respiratory disease complex (PRDC) resulting in significant economic losses worldwide. Vaccination is the most effective approach to disease prevention. Since PRRSV and Mhp co-infections are very common, an efficient dual vaccine against these pathogens is required for the global swine industry. Compared with traditional vaccines, multi-epitope vaccines have several advantages, they are comparatively easy to produce and construct, are chemically stable, and do not have an infectious potential. In this study, to develop a safe and effective vaccine, B cell and T cell epitopes of PRRSV-GP5, PRRSV-M, Mhp-P46, and Mhp-P65 protein had been screened to construct a recombinant epitope protein rEP-PM that has good hydrophilicity, strong antigenicity, and high surface accessibility, and each epitope is independent and complete. After immunization in mice, rEP-PM could induce the production of high levels of antibodies, and it had good immunoreactivity with anti-rEP-PM, anti-PRRSV, and anti-Mhp antibodies. The anti-rEP-PM antibody specifically recognizes proteins from PRRSV and Mhp. Moreover, rEP-PM induced a Th1-dominant cellular immune response in mice. Our results showed that the rEP-PM protein could be a potential candidate for the development of a safe and effective multi-epitope peptide combined vaccine to control PRRSV and Mhp infections. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
4. Age- and sex-specific effects of obesity, metabolic syndrome and its components on back pain: The English Longitudinal Study of Ageing.
- Author
-
Perera, Romain S, Chen, Lingxiao, Ferreira, Manuela L, Arden, Nigel K, Radojčić, Maja R, and Kluzek, Stefan
- Subjects
- *
BACKACHE , *METABOLIC syndrome , *MIDDLE-aged men , *OLDER women , *BODY mass index - Abstract
Objectives: We aimed to investigate age- and sex-specific effects of obesity, metabolic syndrome (MetS) and its components on back pain in middle-aged and older English individuals.Methods: We used data from the English Longitudinal Study of Ageing, wave 2 (2004-2005). Body mass index (BMI) expressed the obesity, while MetS was defined according to revised Adult Treatment Panel (ATP) III criteria. We assessed associations between obesity, MetS and its components with presence and severity of back pain and provided estimates per strata, middle-aged (50-64years) and older (65-79years), women and men.Results: The study sample included 3328 participants, 1021 and 835 middle-aged women and men and 773 and 699 older women and men, respectively. We found that BMI (OR=1.07, 95% CI 1.05-1.09), MetS (OR=1.47, 95% CI 1.22-1.77), high waist circumference (WC), high triglycerides (TG), and high fasting blood glucose were associated with the presence of back pain. Effects of BMI were consistent across the strata. However, MetS was associated with back pain only in women, middle-aged (OR=1.59, 95% CI 1.14-2.21) and older (OR=1.43, 95% CI 1.01-2.05). The MetS component driving this association was high WC, supported by high TG in older women. Higher BMI, presence of MetS, high blood pressure and TG were associated with back pain severity.Conclusions: We found that obesity was associated with the presence and severity of back pain, irrespective of age and sex. However, we found women-specific effects of MetS driven by high WC, indicating that metabolic dysregulation contributes to back pain pathophysiology in women. [ABSTRACT FROM AUTHOR]- Published
- 2022
- Full Text
- View/download PDF
5. Effects of body weight and fat mass on back pain – direct mechanical or indirect through inflammatory and metabolic parameters?
- Author
-
Perera, Romain S, Chen, Lingxiao, Hart, Deborah J, Spector, Tim D, Arden, Nigel K, Ferreira, Manuela L, and Radojčić, Maja R
- Abstract
While reports indicate the association between obesity and back pain, its mechanism is still unclear. Thus, we aimed to investigate the effects of weight and its components on back pain in middle-aged women while considering direct mechanical and indirect effects via inflammatory and metabolic parameters. We used data from the Chingford 1000 Women Study, two follow-ups seven years apart. We assessed effects of weight, body mass index (BMI), total fat mass (TFM), total lean mass (TLM) and total bone mineral density (TBMD), measured by dual-energy X-ray absorptiometry, on back pain episode. We used inflammatory (C-reactive protein, interleukin-6, and tumour necrosis factor-alpha) and metabolic parameters (systolic and diastolic blood pressure, triglyceride, high-density lipoprotein cholesterol, and fasting blood glucose) as mediators of indirect effects. We investigated associations of interest cross-sectionally and longitudinally using binary logistic regression and parallel mediation model. We included 826 Chingford middle-aged women (mean age=60.7, SD=5.9) from the first used follow-up in cross-sectional and mediation analyses and 645 women that attended the follow-up seven years later, in longitudinal analyses. We found that increased weight was directly associated with increased odds of having back pain episode (OR=1.02; 95% CI 1.01–1.03), similarly as BMI (OR=1.05; 95% CI 1.02–1.08) and TFM (OR=1.03; 95% CI 1.01–1.04) consistently across the cross-sectional and longitudinal models, but not TLM or TBMD. However, we did not find consistent indirect effects of weight or its components through measured inflammatory or metabolic parameters on back pain. Our results show that in middle-aged women, weight, BMI and TFM are directly related to back pain, indicating prominence of mechanical loading effect. [Display omitted] • Increased body weight increases the odds of experiencing a back pain episode. • The effect of body weight on back pain is direct. • CRP, IL-6 and TNFα do not mediate the indirect effects of body weight on back pain. • Mediators are not blood pressure, triglycerides, HDL cholesterol or blood glucose. • Weight reduction could decrease obesity-related effect of bodyweight on back pain. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
6. A critical appraisal of clinical practice guidelines on surgical treatments for spinal cord injury.
- Author
-
Zheng, Ruiyuan, Fan, Yuxuan, Guan, Bin, Fu, Runhan, Yao, Liang, Wang, Wei, Li, Guoyu, Zhou, Yue, Chen, Lingxiao, Feng, Shiqing, and Zhou, Hengxing
- Subjects
- *
SPINAL cord injuries , *ONLINE databases - Abstract
Spinal cord injury (SCI) is a global health problem with a heavy economic burden. Surgery is considered as the cornerstone of SCI treatment. Although various organizations have formulated different guidelines on surgical treatment for SCI, the methodological quality of these guidelines has still not been critically appraised. We aim to systematically review and appraise the current guidelines on surgical treatments of SCI and summarize the related recommendations with the quality evaluation of supporting evidence. Systematic review. Medline, Cochrane library, Web of Science, Embase, Google Scholar, and online guideline databases were searched from January 2000 to January 2022. The most updated and recent guidelines containing evidence-based or consensus-based recommendations and established by authoritative associations were included. The Appraisal of Guidelines for Research and Evaluation, 2nd edition instrument containing 6 domains (eg, applicability) was used to appraise the included guidelines. An evidence-grading scale (ie, level of evidence, LOE) was utilized to evaluate the quality of supporting evidence. The supporting evidence was categorized as A (the best quality), B, C, and D (the worst quality). Ten guidelines from 2008 to 2020 were included, however, all of them acquired the lowest scores in the domain of applicability among all the six domains. Fourteen recommendations (eight evidence-based recommendations and six consensus-based recommendations) were totally involved. The SCI types of the population and timing of surgery were studied. Regarding the SCI types of the population, eight guidelines (8/10, 80%), two guidelines (2/10, 20%), and three guidelines (3/10, 30%) recommended surgical treatment for patients with SCI without further clarification of characteristics, incomplete SCI, and traumatic central cord syndrome (TCCS), respectively. Besides, one guideline (1/10, 10%) recommended against surgery for patients with SCI without radiographic abnormality. Regarding the timing of surgery, there were eight guidelines (8/10, 80%), two guidelines (2/10, 20%), and two guidelines (2/10, 20%) with recommendations for patients with SCI without further clarification of characteristics, incomplete SCI, and TCCS, respectively. For patients with SCI without further clarification of characteristics, all eight guidelines (8/8, 100%) recommended for early surgery and five guidelines (5/8, 62.5%) recommended for the specific timing, which ranged from within 8 hours to within 48 hours. For patients with incomplete SCI, two guidelines (2/2, 100%) recommended for early surgery, without specific time thresholds. For patients with TCCS, one guideline (1/2, 50%) recommended for surgery within 24 hours, and another guideline (1/2, 50%) simply recommended for early surgery. The LOE was B in eight recommendations, C in three recommendations, and D in three recommendations. We remind the reader that even the highest quality guidelines often have significant flaws (eg, poor applicability), and some of the conclusions are based on consensus recommendations which is certainly less than ideal. With these caveats, we found most included guidelines (8/10, 80%) recommended early surgical treatment for patients after SCI, which was consistent between evidence-based recommendations and consensus-based recommendations. Regarding the specific timing of surgery, the recommended time threshold did vary, but it was usually within 8 to 48 hours, where the LOE was B to D. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
7. A critical appraisal of clinical practice guidelines for diagnostic imaging in the spinal cord injury.
- Author
-
Guan, Bin, Li, Guoyu, Zheng, Ruiyuan, Fan, Yuxuan, Yao, Liang, Chen, Lingxiao, Feng, Shiqing, and Zhou, Hengxing
- Subjects
- *
DIAGNOSTIC imaging , *SPINAL cord injuries , *DIFFUSION tensor imaging , *MAGNETIC resonance imaging , *CHILD patients , *SPINAL injuries - Abstract
Spinal cord injury (SCI) is a serious health problem which carries a heavy economic burden. Imaging technologies play an important role in the diagnosis of SCI. Although several organizations have developed guidelines for diagnostic imaging of SCI, their quality has not yet been systematically assessed. We aim to conduct a systematic review to appraise SCI guidelines and summarize their recommendations for diagnostic imaging of SCI. Systematic review. We searched Embase, Medline, Web of Science, Cochrane, some guideline-specific databases (eg, Scottish Intercollegiate Guidelines Network) and Google Scholar from January 2000 to January 2022. We included guidelines developed by nationally recognized organizations. If multiple versions could be obtained, we included the latest one. We appraised included guidelines using the Appraisal of Guidelines for Research and Evaluation, 2nd edition instrument which contains six domains (eg, scope and purpose). We also extracted recommendations and assessed their supporting evidence using levels of evidence (LOE). The evidence was categorized as A (the best quality), B, C, and D (the worst quality). Seven guidelines (2008–2020) were included. They all received the lowest scores in the domain of applicability. All guidelines (7/7, 100%) recommended magnetic resonance imaging (MRI) in patients with SCI or SCI without radiographic abnormality (SCIWORA). A total of 12 recommendations involving patient age (eg, adult and child patients), timing of MRI (eg, as soon as possible and in the acute period), symptoms indicated for MRI (eg, a stiff spine and midline tenderness, suspected disc and posterior ligamentous complex injury, and neurological deficit), and types of MRI (eg, T2-weighted imaging and diffusion tensor imaging) were extracted. Among them, the LOE was C in nine (75%) recommendations and D in three (25%) recommendations. Seven guidelines were included in the present systematic review, and all of them showed the worst applicability scores in the Appraisal of Guidelines for Research and Evaluation, 2nd edition instrument. They all weakly recommended MRI for patients with suspected SCI or SCIWORA based on a low LOE. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
8. A critical appraisal of clinical practice guidelines for management of four common complications after spinal cord injury.
- Author
-
Zheng, Ruiyuan, Guan, Bin, Fan, Yuxuan, Fu, Runhan, Yao, Liang, Wang, Wei, Li, Guoyu, Chen, Lingxiao, Zhou, Hengxing, and Feng, Shiqing
- Subjects
- *
LOW-molecular-weight heparin , *SPINAL cord injuries , *PRESSURE ulcers , *URINARY tract infections , *LUNG infections , *DEBRIDEMENT - Abstract
• Systematically reviewed and appraised guidelines through the AGREE II instrument. • Focused on pressure sores, pulmonary infection, urinary tract infection, and venous thromboembolism. • Extracted relevant recommendations and assessed the quality of their supporting evidence. • The quality of supporting evidence ranged from poor to fair. • For venous thromboembolism, recommendations on unfractionated heparin was controversial. Complications such as pressure sores, pulmonary infection, urinary tract infection (UTI), and venous thromboembolism (VTE) are common after spinal cord injury (SCI). These have serious consequences for patients' physical, social, and vocational well-being. Several authoritative organizations have developed guidelines for managing these complications after SCI. We aim to systematically review and appraise guidelines on the management of four common complications (pressure sores, pulmonary infection, UTI, and VTE) after SCI as well as to summarize relevant recommendations and assess the quality of their supporting evidence. Systematic review. We searched Medline, Embase, Cochrane, and Web of Science, as well as guideline-specific databases (eg, National Guideline Clearinghouse) and Google Scholar, from January 2000 to January 2022. We included the most updated guidelines developed by specific authoritative organizations. We evaluated the included guidelines using the Appraisal of Guidelines for Research and Evaluation 2nd edition instrument, which measures six domains (eg, applicability). Recommendations extracted from guidelines were categorized as for, against, or neither for nor against. An evidence assessment was adopted to classify the quality of supporting evidence as poor, fair, or good. Eleven guidelines from 2005 to 2020 were included, all of which, among the six domains, scored lowest in the domain of applicability. For pressure sores, guidelines recommended for skin inspection, repositioning, and the use of pressure reduction equipment as preventive measures and dressings, debridement, and surgery as treatment measures. For pulmonary infection, guidelines recommended for physical (eg, the use of an insufflation–exsufflation device) and pharmacological measures (eg, the use of bronchodilators). For UTI, guidelines recommended for antibiotics as a treatment measure but recommended against cranberries, methenamine salts, and acidification or alkalinization agents as preventive measures. For VTE prophylaxis, five guidelines recommended for low molecular weight heparin (LMWH). Three guidelines recommended against unfractionated heparin, whereas one guideline recommended for it. Most of the supporting evidence was of poor quality (130/139), and the rest was of fair quality (9/139). For pressure sores, pulmonary infection, and UTI, evidence of poor to fair quality indicated consistent recommendations for prevention and treatment measures. For VTE, LMWH was consistently recommended, whereas recommendations on the use of unfractionated heparin were controversial. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
9. A critical appraisal of clinical practice guidelines on pharmacological treatments for spinal cord injury.
- Author
-
Guan, Bin, Fan, Yuxuan, Zheng, Ruiyuan, Fu, Runhan, Yao, Liang, Wang, Wei, Li, Guoyu, Chen, Lingxiao, Zhou, Hengxing, and Feng, Shiqing
- Subjects
- *
DRUG therapy , *SPINAL cord injuries - Abstract
Spinal cord injury brings devastating consequences and huge economic burden. Different authoritative organizations have developed different guidelines for pharmacological treatments of spinal cord injury, but there is a lack of a critical appraisal of them. To systematically review and appraise guidelines regarding their recommendations for pharmacological treatments for spinal cord injury. Systematic review. We searched Medline, Embase, Cochrane, and Web of Science from January 2000 to January 2022 as well as guideline-specific databases (eg, Congress of Neurological Surgeons) and Google Scholar. We included the most updated guideline containing evidence-based recommendations or consensus-based recommendations developed by specific authoritative organizations if multiple versions were available. We appraised guidelines through the Appraisal of Guidelines for Research and Evaluation, 2nd edition instrument consisting of six domains (eg, applicability). With supporting evidence, recommendations were classified as: for, against, neither for nor against. We utilized an evidence assessment system to categorize the quality of supporting evidence as poor, fair, or good. Eight guidelines developed from 2008 to 2020 were included, but all of them scored lowest in the domain of applicability among all six domains. Twelve pharmacological agents (eg, methylprednisolone) were studied. For methylprednisolone, three guidelines (3/8=37.5%) recommended for (one evidence-based and two consensus-based), three (3/8=37.5%) recommended against (all evidence-based), and two (2/8=25%) recommended neither for nor against. For monosialotetrahexosylganglioside (GM-1), one guideline (1/4=25%) recommended for (consensus-based), one (1/4=25%) recommended against (evidence-based), and two (2/4=50%) recommended neither for nor against. For other agents (eg, minocycline), most guidelines (3/5=60%) recommended neither for nor against, one (1/5=20%) recommended against naloxone (evidence-based) and nimodipine (evidence-based), and one (1/5=20%) recommended for neural growth factor (consensus-based). The quality of most of the supporting evidence was poor, and the rest was fair. There were inconsistencies among recommendations for methylprednisolone and GM-1. Evidence-based recommendations tended to recommend against, whereas consensus-based recommendations tended to recommend for. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
10. GOMPS: Global Attention-based Ophthalmic Image Measurement and Postoperative Appearance Prediction System.
- Author
-
Huang, Xingru, Li, Zhi, Lou, Lixia, Dan, Ruilong, Chen, Lingxiao, Zeng, Guodong, Jia, Gangyong, Chen, Xiaodiao, Jin, Qun, Ye, Juan, and Wang, Yaqi
- Subjects
- *
SCLERA , *EYELIDS , *EYE movements , *OPHTHALMIC surgery , *LOGICAL prediction , *COMORBIDITY , *FORECASTING - Abstract
Accurate measurements of ophthalmic parameters and postoperative appearance prediction are essential for the diagnosis and treatment of many ophthalmic diseases. Nevertheless, it remains challenging due to (1) inconsistent ophthalmic image sampling standards, including ocular-camera distance, facial angle, and patient number, (2) complicated ocular morphology, such as subconjunctival hemorrhage, ocular movements, lighting effects, and morphological aging. It is difficult for a model to measure parameters and make predictions in variable sampling methods and morphology conditions. Therefore, the Global attention-based Ophthalmic Image Measurement and Postoperative Appearance Prediction System (GOMPS) is proposed, which quantifies ophthalmic image parameters to diagnose disease and simultaneously predict postoperative appearance of blepharoptosis. By perceiving the global structure of the ophthalmic image, GOMPS makes logical inference predictions of the sclera and cornea morphology, to overcome the above difficulties. Concretely, a global attention unit (GAU) and a novel global attention structure-aware network (GASA-Net) are designed to enhance GOMPS's global structure awareness ability to perform logical reasoning. Extensive experimental results on our collected ophthalmic dataset for diagnosis & prediction (OD2P) demonstrate that GOMPS surpasses the state-of-the-art methods in segmentation accuracy and achieves the current optimal performance in measurement and postoperative prediction under many clinical scenes. • Showcased GOMPS, the initial ophthalmic measurement & post-op look prediction system. • Presented the largest Ophthalmic Dataset for Diagnosis and Prediction OD2P. • Presented GASA-Net for accurate, robust segmentation in difficult ophthalmic images. • Investigated medial canthi & upper eyelid invariance in blepharoptosis treatment. • Realized in-depth ophthalmic surgery simulation using structural information. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.